Maryam Mahmood1, Ayse Tuba Kendi2, Saira Ajmal3, Saira Farid3, John C O'Horo3,4, Panithaya Chareonthaitawee5, Larry M Baddour3,5, M Rizwan Sohail3,5. 1. Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA. mahmood.maryam@mayo.edu. 2. Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN, USA. 3. Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN, 55905, USA. 4. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA. 5. Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Abstract
BACKGROUND: The current diagnosis of infective endocarditis (IE) is based on the modified Duke criteria, which has approximately 80% sensitivity for the diagnosis of native valve endocarditis (NVE), with lower sensitivity for the diagnosis of prosthetic valve endocarditis (PVE) and culture-negative endocarditis. There is preliminary evidence that 18F-FDG PET/CT is an adjunctive diagnostic test with high accuracy reported in small studies to date. We therefore performed a meta-analysis of studies evaluating the use of PET/CT in the diagnosis of IE to establish a more precise estimate of accuracy. METHODS: PubMed, Embase, Cochrane library, CINAHL, Web of Knowledge, and www.clinicaltrials.gov were searched from January 1990 to April 2017 for studies evaluating the accuracy of PET/CT for the evaluation of possible IE. RESULTS: We identified 13 studies involving 537 patients that were included in the meta-analysis. The pooled sensitivity of PET/CT for diagnosis of IE was 76.8% (95% CI 71.8-81.4%; Q = 39.9, P < 0.01; I2 = 69.9%) and the pooled specificity was 77.9% (95% CI 71.9-83.2%; Q = 44.42, P < 0.01; I2 = 73.0%). Diagnostic accuracy was improved for PVE with sensitivity of 80.5% (95% CI 74.1-86.0%; Q = 25.5, P < 0.01; I2 = 72.5%) and specificity of 73.1% (95% CI 63.8-81.2%; Q = 32.1, P < 0.01; I2 = 78.2%). Additional extracardiac foci of infection were found on 17% of patients on whole body PET/CT. CONCLUSION: PET/CT is a useful adjunctive diagnostic tool in the evaluation of diagnostically challenging cases of IE, particularly in prosthetic valve endocarditis. It also has the potential to detect clinically relevant extracardiac foci of infection, malignancy, and other sources of inflammation leading to more appropriate treatment regimens and surgical intervention.
BACKGROUND: The current diagnosis of infective endocarditis (IE) is based on the modified Duke criteria, which has approximately 80% sensitivity for the diagnosis of native valve endocarditis (NVE), with lower sensitivity for the diagnosis of prosthetic valve endocarditis (PVE) and culture-negative endocarditis. There is preliminary evidence that 18F-FDG PET/CT is an adjunctive diagnostic test with high accuracy reported in small studies to date. We therefore performed a meta-analysis of studies evaluating the use of PET/CT in the diagnosis of IE to establish a more precise estimate of accuracy. METHODS: PubMed, Embase, Cochrane library, CINAHL, Web of Knowledge, and www.clinicaltrials.gov were searched from January 1990 to April 2017 for studies evaluating the accuracy of PET/CT for the evaluation of possible IE. RESULTS: We identified 13 studies involving 537 patients that were included in the meta-analysis. The pooled sensitivity of PET/CT for diagnosis of IE was 76.8% (95% CI 71.8-81.4%; Q = 39.9, P < 0.01; I2 = 69.9%) and the pooled specificity was 77.9% (95% CI 71.9-83.2%; Q = 44.42, P < 0.01; I2 = 73.0%). Diagnostic accuracy was improved for PVE with sensitivity of 80.5% (95% CI 74.1-86.0%; Q = 25.5, P < 0.01; I2 = 72.5%) and specificity of 73.1% (95% CI 63.8-81.2%; Q = 32.1, P < 0.01; I2 = 78.2%). Additional extracardiac foci of infection were found on 17% of patients on whole body PET/CT. CONCLUSION: PET/CT is a useful adjunctive diagnostic tool in the evaluation of diagnostically challenging cases of IE, particularly in prosthetic valve endocarditis. It also has the potential to detect clinically relevant extracardiac foci of infection, malignancy, and other sources of inflammation leading to more appropriate treatment regimens and surgical intervention.
Authors: Wilco Tanis; Asbjørn Scholtens; Jesse Habets; Renee B A van den Brink; Lex A van Herwerden; Steven A J Chamuleau; Ricardo P J Budde Journal: JACC Cardiovasc Imaging Date: 2013-09
Authors: Fidel J Vos; Chantal P Bleeker-Rovers; Bart Jan Kullberg; Eddy M M Adang; Wim J G Oyen Journal: J Nucl Med Date: 2011-10-07 Impact factor: 10.057
Authors: G Habib; G Derumeaux; J F Avierinos; J P Casalta; F Jamal; F Volot; M Garcia; J Lefevre; F Biou; A Maximovitch-Rodaminoff; P E Fournier; P Ambrosi; J G Velut; A Cribier; J R Harle; P J Weiller; D Raoult; R Luccioni Journal: J Am Coll Cardiol Date: 1999-06 Impact factor: 24.094
Authors: Tatiana J D Brandão; Carolina A Januario-da-Silva; Marcelo G Correia; Monica Zappa; Jaime A Abrantes; Angela M R Dantas; Wilma Golebiovski; Giovanna Ianini F Barbosa; Clara Weksler; Cristiane C Lamas Journal: Infection Date: 2016-10-22 Impact factor: 3.553
Authors: Soile Pauliina Salomäki; Antti Saraste; Jukka Kemppainen; Jeroen J Bax; Juhani Knuuti; Pirjo Nuutila; Marko Seppänen; Anne Roivainen; Juhani Airaksinen; Laura Pirilä; Jarmo Oksi; Ulla Hohenthal Journal: J Nucl Cardiol Date: 2015-12-09 Impact factor: 5.952
Authors: W Tanis; R P J Budde; I A C van der Bilt; B Delemarre; G Hoohenkerk; J-K van Rooden; A M Scholtens; J Habets; S Chamuleau Journal: Neth Heart J Date: 2016-02 Impact factor: 2.380
Authors: Marty C Tam; Vaiibhav N Patel; Richard L Weinberg; Edward A Hulten; Keith D Aaronson; Francis D Pagani; James R Corbett; Venkatesh L Murthy Journal: JACC Cardiovasc Imaging Date: 2019-07-17
Authors: Sami El-Dalati; Venkatesh L Murthy; Anna B Owczarczyk; Christopher Fagan; James Riddell; Sandro Cinti; Richard L Weinberg Journal: J Nucl Cardiol Date: 2019-09-04 Impact factor: 5.952